• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>risk analysis >Cardiac Sensitization Thresholds of Halon Replacement Chemicals Predicted in Humans by Physiologically‐Based Pharmacokinetic Modeling
【24h】

Cardiac Sensitization Thresholds of Halon Replacement Chemicals Predicted in Humans by Physiologically‐Based Pharmacokinetic Modeling

机译：Cardiac Sensitization Thresholds of Halon Replacement Chemicals Predicted in Humans by Physiologically‐Based Pharmacokinetic Modeling

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Human exposure to halons and halon replacement chemicals is often regulated on the basis of cardiac sensitization potential. The dose‐response data obtained from animal testing are used to determine the no observable adverse effect level (NOAEL) and lowest observable adverse effect level (LOAEL) values. This approach alone does not provide the information necessary to evaluate the cardiac sensitization potential for the chemical of interest under a variety of exposure concentrations and durations. In order to provide a tool for decision‐makers and regulators tasked with setting exposure guidelines for halon replacement chemicals, a quantitative approach was established which allowed exposures to be assessed in terms of the chemical concentrations in blood during the exposure. A physiologically‐based pharmacokinetic (PBPK) model was used to simulate blood concentrations of Halon 1301 (bromotrifluoromethane, CF3Br), HFC‐125 (pentafluoroethane, CHF2CF3), HFC‐227ea (heptafluoropropane, CF3CHFCF3), HCFC‐123 (dichlorotrifluoroethane, CHCl2CF3), and CF3I (trifluoroiodomethane) during inhalation exposures. This work demonstrates a quantitative approach for use in linking chemical inhalation exposures to the levels of chemical in blood achieved during t

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号